Today is officially the first day of the US Food and Drug Administration’s Office of Product Evaluation and Quality – a so-called “Super Office” that the agency hopes will make it more efficient and effective. Regulators say the new model of workflow has already identified safety signals sooner and streamlined their work.
Speaking via video at MedCon 2019 in Cincinnati, OH, Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, announced the first day of the new OPEQ,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?